An individualized treatment regimen with high-dose cabergoline may help women with tumor-related hyperprolactinemic infertility to achieve pregnancy, say researchers from Japan. “Our findings ...

In humans,DA and DA agonists have an inhibitory effect on LH and Pr release which differs in the two sexes and in women in the different phases of the menstrual cycle. We examined the effect of L ...

“HMI-115 is a prolactin receptor blocker, and we're using it to treat endometriosis and some other diseases. It is a first-in-class new mechanism to treat endometriosis,” Hope Medicine CEO Nathan Chen ...

Women who are overweight and obese have lowered prolactin responses to suckling. Women who are obese are at risk for prolonged labors, excessive labor stress, and cesarean birth, all of which ...